Skip to content

Public FDA record

Z-1441-2013: Optovue iVue with Normative Database (NDB) with Software Version 3.0 and 3.1. Intended for in vivo imagi

Recall record Z-1441-2013 for Optovue, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1441-2013
Company in FDA record
Optovue, Inc.
FDA classification date
May 31, 2013
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

Colors from the NDB comparison for Ganglion Cell Complex thickness in the singular OU report in iVue version 3.0 (US) and 3.1(international) are different from those in the individual iWellness ID and OS reports.

Source facts

Action
Optovue sent a Field Correction Notice letter dated May 16, 2013 to all affected customers. The letter identified the product, problem, and actions to be taken by the customers.
Initiated
2013-05-14
Root cause
Software design
Terminated
2013-10-24
Distribution
Distributed Nationwide and in Canada.
Recall number
Z-1441-2013
Recall status
Terminated
CDRH record ID
118193
FDA classified
2013-05-31
Recall event number
65191

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗